Functional evaluation of novel compound heterozygous variants in SLC12A3 of Gitelman syndrome

被引：1

作者：

Wang, Na ^{[1
]}

Yang, Yuanxing ^{[2
]}

Tian, Xiong ^{[3
]}

Fu, Hongjun ^{[2
]}

Chen, Shuaishuai ^{[1
]}

Du, Juping ^{[1
]}

Xu, Mengyi ^{[1
]}

He, Haixia ^{[1
]}

Shen, Bo ^{[1
]}

Xu, Jiaqin ^{[1
]}

机构：

[1] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Clin Lab, 150 Ximen St, Linhai, Peoples R China

[2] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Endocrinol, Linhai, Peoples R China

[3] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Publ Res Platform, Linhai, Peoples R China

来源：

ORPHANET JOURNAL OF RARE DISEASES | 2025年 / 20卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Gitelman syndrome; Hypokalemia; Gene mutation; Loss-of-function; CHINESE PATIENTS; MUTATIONS; GENE; COTRANSPORTER; ASSOCIATION; EXPRESSION; CONSENSUS; SPECTRUM;

D O I：

10.1186/s13023-025-03577-8

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background Gitelman syndrome (GS) is an inherited renal tubular disorder characterized by hypokalemic alkalosis and hypomagnesemia, due to biallelic pathogenic variants in the solute carrier family 12 member 3 (SLC12A3) gene encoding a sodium-chloride (Na-Cl) cotransporter (NCC). This work aimed at identifying SLC12A3 variants in the GS pedigree and reveal the effect of the mutations on protein structure and function. Methods Whole-exome sequencing (WES) and Sanger sequencing were performed in the pedigree. Configuration prediction of two mutant NCC proteins were achieved using SWISS-MODEL. The SLC12A3 missense mutants were generated by site-specific mutagenesis, and the protein expression, location and Na+ uptake activity were assessed by using the HEK293T cell line. Results Genetic analysis identified novel compound heterozygous SLC12A3 variants (c.718G > A/p.E240K and c.2675T > C/p.L892P) in the patient with typical GS phenotype. Both of her parents, elder brother and her son carried the heterozygous p.L892P variant, but only the elder brother exhibited mild hypokalemia. Bioinformatics tools predicted that both mutations were highly species conserved and pathogenic. The prediction of mutant protein indicated that p.E240K and p.L892P altered protein's secondary and three-dimensional (3D) structure and stability. Functional experiments revealed decreased protein expression and Na+ uptake activity caused by these two variants, especially the p.L892P variant. Conclusion Our study presents the genetic and functional evidence for the novel compound heterozygous loss-of-function variants in SLC12A3 that may synergistically cuase GS, and expands the mutation spectrum of SLC12A3 variants in patients with GS.

引用

页数：13

共 35 条

[1] Knoers N.V., Levtchenko E.N., Gitelman syndrome, Orphanet J Rare Dis, 3, (2008)
[2] Hsu Y.J., Yang S.S., Chu N.F., Sytwu H.K., Cheng C.J., Lin S.H., Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure, Nephrol Dial Transpl, 24, 4, pp. 1170-1175, (2009)
[3] Wang T., Chen Y., Yin X., Qiu H., Novel heterozygous mutation of SLC12A3 gene in Gitelman syndrome, QJM, 114, 7, pp. 513-515, (2021)
[4] Glaudemans B., Yntema H.G., San-Cristobal P., Schoots J., Pfundt R., Kamsteeg E.J., Bindels R.J., Knoers N.V., Hoenderop J.G., Hoefsloot L.H., Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome, Eur J Hum Genet, 20, 3, pp. 263-270, (2012)
[5] Zhang L., Huang K., Wang S., Fu H., Wang J., Shen H., Lu Z., Chen J., Bao Y., Feng C., Dong G., Mao J., Clinical and genetic features in 31 serial Chinese children with Gitelman Syndrome, Front Pediatr, 9, (2021)
[6] Blanchard A., Bockenhauer D., Bolignano D., Calo L.A., Cosyns E., Devuyst O., Ellison D.H., Karet Frankl F.E., Knoers N.V., Konrad M., Lin S.H., Vargas-Poussou R., Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 91, 1, pp. 24-33, (2017)
[7] Zhang L., Peng X., Zhao B., Xia P., Wen Y., Ye W., Li X., Li X., Ye W., Cheng H., Chen L., Clinicopathological features of Gitelman syndrome with proteinuria and renal dysfunction, Nephron, (2023)
[8] Liu Z., Wang S., Zhang R., Wang C., Lu J., Shao L., A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report, BMC Med Genomics, 14, 1, (2021)
[9] Palazzo V., Raglianti V., Landini S., Cirillo L., Errichiello C., Buti E., Artuso R., Tiberi L., Vergani D., Dirupo E., Romagnani P., Mazzinghi B., Becherucci F., Clinical and genetic characterization of patients with Bartter and Gitelman Syndrome, Int J Mol Sci, 23, 10, (2022)
[10] Zelikovic I., Szargel R., Hawash A., Labay V., Hatib I., Cohen N., Nakhoul F., A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes, Kidney Int, 63, 1, pp. 24-32, (2003)

← 1 2 3 4 →